Combined Phacoaspiration and Angle Surgery Versus Phacoaspiration in Pediatric Cataract

NCT05401760 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-09-08

No results posted yet for this study

Summary

The aim of this study is to report the effectiveness of phacoaspiration when combined with angle surgery in preventing postoperative glaucoma following pediatric cataract surgery

Conditions

  • Pediatric Glaucoma

Interventions

PROCEDURE

Group A :combined phacoaspiration and angle surgery

* Partial thickness scleral flap to access the canal of schlemm. * 2 side ports will be fashioned. * Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done. * The nucleus and cortex will be aspirated. * Posterior capsulrehxis and limited anterior vitrectomy will be done. * Corneal incisions will be sutured with 10-0 Nylon suture. * Using metal trabeculotomes to open thetrabecular meshwork after accessing the canal of schlemm. * Suturing of scleral flap with 10-0 Nylon suture.

PROCEDURE

Group B : phacoaspiration only

* 2 side ports will be fashioned. * Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done. * The nucleus and cortex will be aspirated. * Posterior capsulrehxis and limited anterior vitrectomy will be done. * Corneal incisions will be sutured with 10-0 Nylon suture.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2022-11-30
Completion
2023-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05401760 on ClinicalTrials.gov